Psychological well-being of early and continuously treated phenylketonuria patients

Alena Gerlinde Thiele1, Nicole Spieß1,2, Rudolf Ascherl1

  • 1Hospital for Children and Adolescents, Center for Pediatric Research Leipzig (CPL), Department of Women and Child Health, University Hospital, University of Leipzig Leipzig Germany.

JIMD Reports
|May 12, 2021
PubMed

Insights

Phenylketonuria (PKU) patients generally show normal psychological strengths and behavioral difficulties. However, adolescent PKU girls may be at risk for emotional problems, warranting specific attention.

Area of Science:

  • Pediatric Psychology
  • Metabolic Disorders
  • Child Psychiatry

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disease requiring lifelong treatment.
  • Despite treatment advances, PKU can negatively impact quality of life and psychological well-being.
  • Early diagnosis and continuous treatment are crucial for managing PKU.

Purpose of the Study:

  • To screen psychological strengths and behavioral difficulties in children with PKU.
  • To assess the impact of PKU on psychological well-being in early diagnosed and treated individuals.
  • To compare psychological profiles of PKU patients with healthy controls.

Main Methods:

  • The Strengths and Difficulties Questionnaire (SDQ) was used for evaluation.
  • 49 PKU patients (2-17 years) and 98 healthy controls were assessed.
  • Parent-report and self-report (for adolescents) data were collected and analyzed.

Main Results:

  • Overall, PKU patients exhibited normal psychological strengths and behavioral difficulties scores.
  • PKU boys (2-10 years) showed higher prosocial behavior; adolescent boys had fewer conduct problems.
  • Adolescent PKU girls reported more emotional problems, impacting total difficulties scores.

Conclusions:

  • The SDQ is a suitable tool for assessing PKU patients.
  • Specific psychological aspects in PKU require tailored evaluation.
  • Adolescent girls with PKU may need targeted support for emotional well-being.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
470
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
168
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
286
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
974